Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Brazilian ICUs test simple training to cut antibiotic overuse

NCT ID NCT07093450

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now This study
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study tests whether an educational program can help doctors in intensive care units (ICUs) use fewer antibiotics. The program includes training sessions and feedback based on the latest guidelines. Researchers will compare antibiotic use in ICUs before and after the program, involving about 9,000 patients across multiple Brazilian ICUs. They will also check if reducing antibiotics affects patient safety, such as death rates or length of stay.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
Educational quality improvement intervention
What this could lead to
If successful, this could show that training and feedback help ICUs use antibiotics more wisely, reducing resistance and side effects without harming patients.
What could go wrong
This is an implementation study, not a drug trial. Results depend on how well doctors follow the program, and it may not work in other settings or countries.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

About 9,000 people

The number the study aims to enrol. It can still change while the study runs.

Started

Jun 2025

Expected to finish

Jul 2026

An estimate. End dates often move.

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

18 years and older

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Intensive care units inclusion Criteria: * ICU leadership acceptance to participant in the quality improvement intervention; * Hospital infection control leadership acceptance to participant in the quality improvement intervention; * ICU participation in the IMPACTO-MR platform with high quality data; * ICU potential for quality improvement based on a subjective assessment of the ICU and hospital infection leaderships Intensive care units exclusion Criteria: \- Absence of local IRB approval Participants inclusion Criteria: * All patients admitted to the intensive care unit Participants exclusion Criteria: * Patients younger than 18 years-old will be excluded from individual-level analysis

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Antimicrobial stewardship are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

How to take part

Only the study team decides who joins. These are the ways to reach them.

  1. The places running it

    9 sites. The list below names each one and where it is.

  2. The official record

    ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.

    Open the record ↗

  3. A doctor treating you

    A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.

Contacts and locations

Locations

  • Hospital Maternidade São José

    RECRUITING

    Colatina, Espírito Santo, Brazil

  • Hospital Municipal de Maringá

    RECRUITING

    Maringá, Paraná, Brazil

  • Hospital Naval Marcílio Dias

    RECRUITING

    Rio de Janeiro, Rio de Janeiro, Brazil

  • Hospital Onofre Lopes

    RECRUITING

    Natal, Rio Grande do Norte, Brazil

  • Hospital Pelópidas Silveira

    RECRUITING

    Recife, Pernambuco, Brazil

  • Hospital Santa Cruz

    RECRUITING

    Santa Cruz do Sul, Rio Grande do Sul, Brazil

  • Hospital de Pronto Socorro

    RECRUITING

    Porto Alegre, Rio Grande do Sul, Brazil

  • Santa Casa de Misericórdia de Barretos

    RECRUITING

    Barretos, São Paulo, Brazil

  • Santa Casa de Misericórdia de Passos

    RECRUITING

    Passos, Minas Gerais, Brazil

More trials for these conditions

Other studies related to the condition(s) this trial covers.